SECTOR : Medical devices
ENTRY DATE : 2019
BUSINESS : Venture Capital
WEB : tissium.com
Development of synthetic programmable biomorphic polymers
Founded in 2013, the mission of Tissium is to disrupt the field of surgery and positively impact the lives of patients through the development of its platform of biomorphic programmable polymers.
PRESS RELEASE :
20/11/2019 • TISSIUM Closes €39M Series B Funding Round